Identification of new ClpC1-NTD binders for Mycobacterium tuberculosis drug development
Abstract MtbClpC1 is a promising drug target against tuberculosis. Recent studies have shown that several natural product antibiotics targeting the unfoldase N-terminal domain can impair MtbClpC1 function resulting in cell death. While the pharmacological properties of these natural product antibiot...
Saved in:
Main Authors: | Katharina Weinhäupl, Louis Meuret, Sandy Desrat, Fanny Roussy, Nelly Morellet, Sandra Beaupierre, Catherine Guillou, Carine van Heijenoort, Olga Abian, Sonia Vega, Ian Wolf, Tatos Akopian, Olga Krandor, Eric Rubin, Adrian Velazquez-Campoy, Diego Gauto, Hugo Fraga |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-87535-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigation of the Effects of Fosfomycin in Kidney Damage Caused by CLP-Induced Sepsis
by: Ilknur Esen Yildiz, et al.
Published: (2024-12-01) -
A strategy for controlling Hypervirulent Klebsiella pneumoniae: inhibition of ClpV expression
by: Wenke Liu, et al.
Published: (2025-01-01) -
Impact of the new hazard classes in the CLP regulation on EU chemicals legislation
by: Diana Kättström, et al.
Published: (2025-01-01) -
ClpB chaperone as a promising target for antimicrobial therapy: A narrative review
by: Sachini J. Udari, et al.
Published: (2025-01-01) -
The known unknowns of the Hsp90 chaperone
by: Laura-Marie Silbermann, et al.
Published: (2024-12-01)